DZ1796A1 - Dérivés de pipéridinyle nouveaux, procédé pour leur préparation et compositions pharmaceutique les contenant. - Google Patents
Dérivés de pipéridinyle nouveaux, procédé pour leur préparation et compositions pharmaceutique les contenant.Info
- Publication number
- DZ1796A1 DZ1796A1 DZ940075A DZ940075A DZ1796A1 DZ 1796 A1 DZ1796 A1 DZ 1796A1 DZ 940075 A DZ940075 A DZ 940075A DZ 940075 A DZ940075 A DZ 940075A DZ 1796 A1 DZ1796 A1 DZ 1796A1
- Authority
- DZ
- Algeria
- Prior art keywords
- preparation
- pharmaceutical compositions
- compositions containing
- piperidinyl derivatives
- new piperidinyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939314250A GB9314250D0 (en) | 1993-07-09 | 1993-07-09 | Piperidinyl compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DZ1796A1 true DZ1796A1 (fr) | 2002-02-17 |
Family
ID=10738563
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DZ940075A DZ1796A1 (fr) | 1993-07-09 | 1994-07-09 | Dérivés de pipéridinyle nouveaux, procédé pour leur préparation et compositions pharmaceutique les contenant. |
Country Status (26)
| Country | Link |
|---|---|
| EP (1) | EP0707579B1 (fr) |
| JP (1) | JP3031634B2 (fr) |
| AP (1) | AP521A (fr) |
| AT (1) | ATE175963T1 (fr) |
| AU (1) | AU687414B2 (fr) |
| CA (1) | CA2163994A1 (fr) |
| CZ (1) | CZ4496A3 (fr) |
| DE (1) | DE69416131T2 (fr) |
| DK (1) | DK0707579T3 (fr) |
| DZ (1) | DZ1796A1 (fr) |
| ES (1) | ES2128567T3 (fr) |
| FI (1) | FI960084A (fr) |
| GB (2) | GB9314250D0 (fr) |
| HR (1) | HRP940394A2 (fr) |
| HU (1) | HU219239B (fr) |
| IL (1) | IL110222A (fr) |
| MY (1) | MY111604A (fr) |
| NO (1) | NO960080D0 (fr) |
| NZ (1) | NZ268048A (fr) |
| PL (1) | PL312498A1 (fr) |
| RU (1) | RU2128178C1 (fr) |
| SG (1) | SG45425A1 (fr) |
| SI (1) | SI9400281A (fr) |
| SK (1) | SK2996A3 (fr) |
| WO (1) | WO1995001974A1 (fr) |
| ZA (1) | ZA944930B (fr) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9117639D0 (en) * | 1991-08-15 | 1991-10-02 | Ici Plc | Therapeutic compounds |
-
1993
- 1993-07-09 GB GB939314250A patent/GB9314250D0/en active Pending
-
1994
- 1994-06-30 AP APAP/P/1994/000652A patent/AP521A/en active
- 1994-07-01 GB GB9413235A patent/GB9413235D0/en active Pending
- 1994-07-04 WO PCT/GB1994/001439 patent/WO1995001974A1/fr not_active Application Discontinuation
- 1994-07-04 CZ CZ9644A patent/CZ4496A3/cs unknown
- 1994-07-04 EP EP94919752A patent/EP0707579B1/fr not_active Expired - Lifetime
- 1994-07-04 AT AT94919752T patent/ATE175963T1/de not_active IP Right Cessation
- 1994-07-04 DK DK94919752T patent/DK0707579T3/da active
- 1994-07-04 SG SG1996007272A patent/SG45425A1/en unknown
- 1994-07-04 NZ NZ268048A patent/NZ268048A/en unknown
- 1994-07-04 CA CA002163994A patent/CA2163994A1/fr not_active Abandoned
- 1994-07-04 DE DE69416131T patent/DE69416131T2/de not_active Expired - Lifetime
- 1994-07-04 SK SK29-96A patent/SK2996A3/sk unknown
- 1994-07-04 PL PL94312498A patent/PL312498A1/xx unknown
- 1994-07-04 RU RU96102585A patent/RU2128178C1/ru active
- 1994-07-04 ES ES94919752T patent/ES2128567T3/es not_active Expired - Lifetime
- 1994-07-04 JP JP7503893A patent/JP3031634B2/ja not_active Expired - Fee Related
- 1994-07-04 HU HU9503554A patent/HU219239B/hu not_active IP Right Cessation
- 1994-07-04 AU AU70779/94A patent/AU687414B2/en not_active Ceased
- 1994-07-05 IL IL11022294A patent/IL110222A/xx not_active IP Right Cessation
- 1994-07-06 HR HR9314250.3A patent/HRP940394A2/xx not_active Application Discontinuation
- 1994-07-07 ZA ZA944930A patent/ZA944930B/xx unknown
- 1994-07-08 SI SI9400281A patent/SI9400281A/sl unknown
- 1994-07-09 MY MYPI94001799A patent/MY111604A/en unknown
- 1994-07-09 DZ DZ940075A patent/DZ1796A1/fr active
-
1996
- 1996-01-08 NO NO960080A patent/NO960080D0/no not_active Application Discontinuation
- 1996-01-08 FI FI960084A patent/FI960084A/fi unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DZ1957A1 (fr) | Dérivés de pipéridine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
| DZ1889A1 (fr) | Dérivés de quinoléine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
| DZ2128A1 (fr) | Composés nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
| DZ2300A1 (fr) | Dérivés 6,5-hétérobicycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
| DZ2299A1 (fr) | Dérivés 6,6-hétérobicycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
| DZ2197A1 (fr) | Dérivés de 6-phénylpyridyl-2-amine, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
| DZ2962A1 (fr) | Dérivés de 3-azabicycloÄ3,1,0Ühexane nouveaux, procédé pour leur préparation et compositions les contenant. | |
| DZ2045A1 (fr) | Amides thérapeutiques, procédé pour leur préparation et compositions les contenant. | |
| CY2537B1 (fr) | Composés hétérocycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant | |
| DZ2303A1 (fr) | Dérivés d'indazole nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
| DZ2891A1 (fr) | Dérivés de tétrahydroquinoléines substués nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
| DZ2634A1 (fr) | Dérivés de pleuromutiline nouveaux procédé pour leur préparation et compositions pharmaceutiques lescontenant. | |
| DZ2581A1 (fr) | Dérivés d'acides aryloxyarylsulfonylaminohydroxamiques procédé pour leur préparation et compositionspharmaceutiques les contenant. | |
| MA26659A1 (fr) | Dérivés de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procédé pour leur préparation. | |
| DZ2889A1 (fr) | 4-Carboxyamino-2-méthyl-1,2,3,4-tétrahydroquinoléines, procédé pour leur préparation et compositionspharmaceutiques les contenant. | |
| DZ2465A1 (fr) | Pyrazolopyrimidinones nouvelles procédé pour leur préparation et compositions les contenant. | |
| OA08647A (fr) | Dérivés d'imidazole, procédés pour leur préparation et composition pharmaceutique les contenant. | |
| DZ2870A1 (fr) | Dérivés d'acide hydroxypipécolate-hydroxamique nouveaux, procédé pour leur préparation et compositi ons pharmaceutiques les contenant. | |
| OA09378A (fr) | "Nouveaux dérivés de la pipéridine, de la tétrahydropyridine et de la pyrrolidine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent". | |
| DZ2777A1 (fr) | Dérivés de quinazolinamines nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
| DZ2217A1 (fr) | Dérivés d'imidazole substitués, procédé pour leur préparation et compositions les contenant. | |
| DZ3045A1 (fr) | Dérivés de i 3-méthyl-érythromycine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
| DZ2550A1 (fr) | Dérivés d'azétidinylpropylpipéridine procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
| DZ2498A1 (fr) | Dérivés de quinoléine nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
| DZ2155A1 (fr) | Aazétidines, procédé pour leur préparation, et co mpositions pharmaceutiques les contenant. |